Business Context and Reporting Period
Company: Cocrystal Pharma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 4, 2019
Event: Regulation FD Disclosure regarding a corporate presentation at the 2019 Cantor Fitzgerald Global Healthcare Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the timing and availability of a corporate presentation.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document references an attached presentation (Exhibit 99.1) for further details.
Guidance, Outlook, and Risks
- Management Commentary: James Martin, Chief Financial Officer, presented at the 2019 Cantor Fitzgerald Global Healthcare Conference on October 4, 2019, beginning at 1:45 p.m. ET.
- Legal Status of Information: The information contained in this Item 7.01 and the accompanying presentation is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings.
- Exhibits: Exhibit 99.1 contains the "Cocrystal Pharma, Inc. Corporate Presentation, dated October 2019."
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for specific financial data, pipeline updates, and strategic outlook not included in this summary.
- Verify the date and time of the conference presentation (October 4, 2019, 1:45 p.m. ET) against market records.
- Note that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.